secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001104659-26-043970
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx sells Lab Products to Eurobio for $170M; Q1 rev up 39% to $118M
----------------------------------------------------------------------

- Divests Lab Products (IVD kits) to Eurobio Scientific for $170M cash; expected close by end of Q3 2026.
- Preliminary Q1 2026 revenue ~$118M (+39% YoY); Testing Services revenue ~$91M (+48% YoY) on volume of ~54,900 (+17%).
- Patient & Digital Solutions revenue ~$16M (+33% YoY); Lab Products revenue ~$10M (-4% YoY).
- Cash, equivalents, and marketable securities ~$198M as of Mar 31, 2026.
- Retains exclusive North American distribution rights for certain Eurobio post-transplant monitoring IVD tests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000110465926043970/0001104659-26-043970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000110465926043970/tm2611749d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-043970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer